Johns Hopkins ABX GuideBrand Names

Diloxanide furoate

Paul A. Pham, Pharm.D. BCPS, Kathryn Dzintars, Pharm.D., BCPS
Diloxanide furoate is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Johns Hopkins Guides

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Drug not currently available for use in the U.S.
    • Also known as in the literature as entamide furoate or entamide.
  • CDC conducted a study with investigational use of the drug between 1977-1990.

NON-FDA APPROVED USES

  • Amebiasis limited to the GI lumen, caused by Entamoeba histolytica.
  • As combination therapy with other antiprotozoals such as nitroimidazoles for the treatment of invasive or extraintestinal amebiasis. Diloxanide furoate is not a tissue amoebicide and therefore in extraintestinal infections of E. histolytica, another agent (specifically a "tissue amoebicide" like Metronidazole) should be considered for use in combination with diloxanide furoate.

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: January 13, 2016